Medico Remedies Limited

NSE MEDICO.NS

Medico Remedies Limited Revenue for the year ending March 31, 2024: USD 17.37 M

Medico Remedies Limited Revenue is USD 17.37 M for the year ending March 31, 2024, a 1.68% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Medico Remedies Limited Revenue for the year ending March 31, 2023 was USD 17.09 M, a 9.63% change year over year.
Medico Remedies Limited Revenue for the year ending March 31, 2022 was USD 15.59 M, a -6.75% change year over year.
Medico Remedies Limited Revenue for the year ending March 31, 2021 was USD 16.71 M, a 42.10% change year over year.
Medico Remedies Limited Revenue for the year ending March 31, 2020 was USD 11.76 M, a -16.33% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

NSE: MEDICO.NS

Medico Remedies Limited

CEO	Mr. Haresh Kapurlal Mehta
IPO Date	May 26, 2022
Location	India
Headquarters	1105/1106, Hubtown Solaris
Employees	193
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.

Key trends

Past 5 years